Dimethyl fumarát (Tecfidera, enterosolventní tvrdé tobolky) v léčbě relabující roztroušené sklerózy mozkomíšní – klinická účinnost a bezpečnostní profil
| Title in English | Dimethylfumarate in the treatment of relapsing multiple sclerosis – clinical efficacy and safety |
|---|---|
| Authors | |
| Year of publication | 2017 |
| Type | Popularization text |
| MU Faculty or unit | |
| Citation | |
| Description | Dimethylfumarate is an efficient medicine in therapy of relapsing-remitting multiple sclerosis. It has significant clinical efficiency and good safety profile. Along with fingolimod, it belongs to the first and half line line therapy to which the patients may be escalated if the first-line therapy fails. Its advantages include monitoring of its efficacy and safety during the therapy. |